找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays; Franz J. Hock,Michael K. Pugsley Living reference work 20220th edition

[復(fù)制鏈接]
查看: 38862|回復(fù): 63
樓主
發(fā)表于 2025-3-21 17:37:23 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
編輯Franz J. Hock,Michael K. Pugsley
視頻videohttp://file.papertrans.cn/284/283079/283079.mp4
概述A landmark in the continuously changing world of drugs.Essential reading for scientists and managers involved in drug finding, drug development and decision making.Of use for government institutions a
圖書封面Titlebook: Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;  Franz J. Hock,Michael K. Pugsley Living reference work 20220th edition
描述.The third edition of ‘Drug Discovery and Evaluation’ presents an expanded and updated version of one of the classic reference handbooks on safety and pharmacokinetic assays. Each assay description is sufficiently outlined and equipped with outstanding literature references. This comprehensive handbook mainly addresses the needs of pharmacological institutes and research groups working in this area..
出版日期Living reference work 20220th edition
關(guān)鍵詞Bioanalytical Assays; Clinical Studies; Safety Assays; Safety Pharmacokinetics; Safety Pharmacology; Safe
doihttps://doi.org/10.1007/978-3-030-73317-9
isbn_ebook978-3-030-73317-9
The information of publication is updating

書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays影響因子(影響力)




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays影響因子(影響力)學(xué)科排名




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays網(wǎng)絡(luò)公開度




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays被引頻次




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays被引頻次學(xué)科排名




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays年度引用




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays年度引用學(xué)科排名




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays讀者反饋




書目名稱Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-22 00:03:54 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:53:48 | 只看該作者
地板
發(fā)表于 2025-3-22 05:00:21 | 只看該作者
Magnetic Resonance Imaging in Pharmaceutical Safety Assessment,arkers identified in preclinical safety assessment studies for use in clinical drug safety studies..Imaging technologies provide powerful insights into the biological effects of pharmaceuticals and can contribute important biomarkers that aid in the development of new therapies to treat disease.
5#
發(fā)表于 2025-3-22 08:57:45 | 只看該作者
Biomaterials in Their Role in Creating New Approaches for the Delivery of Drugs, Proteins, Nucleic al-based drug delivery system is unique to the drug, peptide, or protein employed in the system. Therefore, this chapter focuses on the safety considerations along with the therapeutic efficacy offered by this evolving developing area of therapeutics.
6#
發(fā)表于 2025-3-22 16:34:26 | 只看該作者
7#
發(fā)表于 2025-3-22 19:57:01 | 只看該作者
Distribution: Across Barriers,barrier. Meanwhile, there exist several in vitro systems to study drug permeation across this special blood–brain barrier (section “Blood–Brain Barrier (BBB)”). They cover primary cultures of brain endothelial cells in monoculture or as coculture with astrocytes or pericytes (section “Primary Cultur
8#
發(fā)表于 2025-3-22 21:20:18 | 只看該作者
Drug Safety Assessment,. Guidelines hereby serve to optimize and facilitate development of harmonized desirable standards to optimize research and regulations, and to accelerate their implementation..The aim of this article is to summarize the complex procedures needed to create guidelines and to support their use. The ma
9#
發(fā)表于 2025-3-23 01:43:39 | 只看該作者
10#
發(fā)表于 2025-3-23 09:13:41 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 09:07
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
壶关县| 台江县| 奎屯市| 临桂县| 吐鲁番市| 临汾市| 莱阳市| 泰和县| 浦县| 龙川县| 扶余县| 台东县| 宜州市| 龙江县| 九龙坡区| 常熟市| 噶尔县| 安丘市| 新和县| 石城县| 江山市| 华坪县| 蓬莱市| 招远市| 孟州市| 尉犁县| 杭锦旗| 邛崃市| 和硕县| 台湾省| 萍乡市| 济南市| 新泰市| 镇巴县| 昌黎县| 盐城市| 寿宁县| 满城县| 江华| 石家庄市| 富裕县|